Cart 0

We are a Cannabis tech company based out of Kelowna, BC.


What We Do

VSSL specializes in the development of proprietary genetics, cultivation and extraction pipelines.

Our Team

Kyle Remenda - CEO

Kyle is the CEO of VSSL and a passionate advocate within the medical marijuana industry. Kyle is the visionary behind VSSL, ensuring that they are the first choice for companies and individuals as their trusted source of marijuana for medical purposes.

Before starting VSSL, Kyle worked in the medical marijuana industry with established legal grow operations in North America. Within Kyle’s pursuit to create and sample the best marijuana around the globe, he has assembled ample expertise of plant breeding, production craft and is more than familiar with the lay of the land within the thriving marijuana industry.

Kyle has worked in various leadership and consulting roles in North America. While working  As a result, he has a track record for leading, managing and delivering consistent consumable medicine.


Philippe Henry - CSO/PHD Genetics

Philippe is a Population Geneticist and Cannasseur. His recent research focuses on using genomic and bioinformatic tools to shed light on the genetic basis of key traits of the Cannabis plant and the Cannabis-Human relationship. His accounts include LPs, section 9 dealers, dispensaries, extraction technologists and international corporations whose primary target is the development and maintenance of elite Cannabis varieties and delivery systems. In addition to developing protocols for diagnostic tools and process optimization, he is also the principal investigator of the Recreational Genomics Consortium and 420andme, two research endeavours developing a comprehensive knowledge base to harness the diverse Cannabis gene pools to enhance our understanding of the therapeutic potential of Cannabis and its derivatives. 

 - Technical Advisor at Medcann SAS Columbia
 - Head Geneticist at OhCannabis Inc
 - Adjunct Professor at UNBC


Damian Solomon - Cultivation Expert

Damian has over 20 years of experience in greenhouse management, traditional horticulture and controlled environment growing systems. He has worked for companies like Eurofresh Farms (North America’s largest hydroponic greenhouse operation), Grimmway Farms (North America’s largest farming company), and DeRuiter Seeds/Monsanto (global seed company specializing in greenhouse specific vegetable seeds). Since 2014 he has been involved in the commercial cannabis industry as Director of Cultivation & Ag Technology for Medmen where he leveraged his vast experience in controlled environments to bring best-of-class procedures, processes and technology into the cannabis space.

Recently, Damian left Medmen to start his own horticultural consulting company, Plant Geek Consulting, LLC as he saw a compelling opportunity to offer his years of understanding, insight and horticultural expertise to his clients. He has travelled the world visiting greenhouses and speaking with growers to share agronomic advice and experience and provide high-level consulting services. Damian is well known in the industry and considered an expert in the field of controlled environment agriculture. Mr. Solomon was awarded a BS in Plant Sciences/Crop Production from the University of Arizona’s College of Agriculture. In 2015, he was recognized by University of Arizona’s College of Agriculture and awarded the CEAC Mission Award for outstanding leadership and exemplary service in Controlled Environment Agriculture. Damian is forward thinking and loves to blend the art of growing crops with applied technology to optimize results.


Malcolm Lamont - Lead Scientist

Malcolm Lamont draws upon over 20 years of practical experience in the plant biotechnology industry. During this time Malcolm created advanced Tissue Culture based propagation systems and plant performance enhancement technologies as the basis for generating superior plant species. Plant species experiencing this technology gain, increase in key metrics including growth, resilience, yield and quality; and hence deliver substantial commercial opportunities.

Malcolm has headed research teams for a number of International and Australian companies, with diverse backgrounds ranging from increasing growth rates in forestry trees, to developing biological and engineering solutions for carbon capture from coal fired power stations, and to the natural rehabilitation of mine sites and waste water streams.

Malcolm has worked successfully with several Industry Majors, including the Swiss-based agricultural giant Syngenta, the world’s largest pulp and paper conglomerate Sinar Mas, Spain’s energy giant Abengoa, the United Kingdom’s British Gas, as well as a number of other companies.

Malcolm has focused heavily on new technologies and approaches to plant improvements and induction of disease resistance in plants, while continuing to develop plant based solutions for a number of environmental problems through induced adaptation.


Robert Hibberd- CFO

Robert is a Chartered Accountant / Chartered Professional Accountant (British Columbia), Certified Public Accountant (Illinois), Certified Management Consultant (Canadian Institute of Management Consultants - Honour Roll), Corporate Finance professional (Canadian Institute of Chartered Professional Accountants), and graduate from the University of Toronto (Bachelor of Arts with Honours).

Robert was a former Assistant Vice President of PricewaterhouseCoopers Corporate Finance Inc., and has more than 20 years experience consulting and leading Initial Public Offerings, acquisitions, financing and divestitures.

Robert’s past roles include Co-Founder and Chief Financial Officer of both WesternOne Equity Income Fund and of American Hotel Income Properties REIT. He was instrumental in founding and taking both companies public, and for the latter company acquiring the initial portfolio of 32 hotels (2,565 guestrooms), facilitating its February 2013 IPO and growing that initial acquired portfolio to 116 hotels (7,048 guestrooms), and increasing enterprise value from $150 million to over $1.4 billion by the end of 2017.



Name *